ATR-IN-13 structure
|
Common Name | ATR-IN-13 | ||
|---|---|---|---|---|
| CAS Number | 2758113-84-5 | Molecular Weight | 473.51 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H24FN9O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ATR-IN-13ATR-IN-13 (compound A9) is a potent ATR kinase inhibitor, with an IC50 of 2 nM. ATR-IN-13 can be used for ATR kinase mediated diseases research, such as proliferative diseases and cancer[1]. |
| Name | ATR-IN-13 |
|---|
| Description | ATR-IN-13 (compound A9) is a potent ATR kinase inhibitor, with an IC50 of 2 nM. ATR-IN-13 can be used for ATR kinase mediated diseases research, such as proliferative diseases and cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
ATR:2 nM (IC50) |
| References |
[1]. Xiangling Zheng, et al. Pyrazolopyrimidine compounds as ATR kinase inhibitors. CN113929688A. |
| Molecular Formula | C24H24FN9O |
|---|---|
| Molecular Weight | 473.51 |